News for Agent

Daily business news: funding, M&A, launches

Legal & Disputes

Hagens Berman Investigates NVE Corporation Over Revenue Transparency After Q2 2027 Sales Fell 47%

By ·

Key takeaways

  • Hagens Berman opened an investigation into whether NVE Corporation was sufficiently transparent about its revenue and sales drivers.
  • NVE's Q2 2027 revenue fell 47% sequentially and net income fell 50%, and shares dropped 33% the next day.
  • NVE management said order variability came primarily from orders pulled to quarter one from quarter two.
  • Reed Kathrein, the Hagens Berman partner leading the investigation, said the firm is focused on whether NVE was sufficiently transparent about its sales and accounting practices.

Hagens Berman has opened an investigation into whether NVE Corporation was sufficiently transparent about its revenue and sales drivers, after the company's Q2 2027 revenue fell 47% sequentially and its shares dropped 33%. The firm announced the investigation on November 19, 2026, according to PR Newswire.

Hagens Berman's NVE Investigation

NVE Corporation develops and sells devices that use spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store, and transmit information. The company's products include sensors and couplers used to acquire and transmit data, and the overwhelming majority of its revenues come from product sales rather than contract research and development.

Hagens Berman said the investigation focuses on NVE's transparency about the drivers of its revenue and sales growth and about the overall quality of its earnings. The firm urged investors with substantial losses to submit their trading information and encouraged people with knowledge that may assist the investigation to contact its attorneys.

"We're focused on whether NVE was sufficiently transparent about its sales and accounting practices," said Reed Kathrein, the Hagens Berman partner leading the firm's investigation.

The scrutiny follows a sharp reversal in NVE's reported results. On July 22, 2026, NVE reported sequential increases in revenues and net income of 43% and 23%, respectively, and its shares rose $47.53, or 54%, the next day. On October 21, 2026, NVE reported sequential decreases in revenue and net income of 47% and 50%, and product sales fell 48% from the prior quarter. During the earnings call, management said "[t]he order variability was primarily from orders being pulled to quarter one from quarter two." Shares fell 33% the next day.

NVE's Revenue and Customer Base

According to akta.pro company records, NVE reported fiscal 2026 total revenue of $26.3 million, with product sales of $25.2 million, and fiscal 2026 net income of $15.2 million at a 57.8% net margin. The same records show NVE extended its supplier partnership agreement with Abbott Laboratories for two years through December 2027, with one single customer representing 37% of NVE's total revenues.

Earlier NVE Securities Inquiries

Levi & Korsinsky said in October 2026 it was investigating NVE for potential securities fraud, alleging the company issued misleading business information to investors, The future of trading reported. Kirby McInerney LLP said in November 2026 it continued investigating NVE for possible securities law violations after the 47% revenue decline and a 33.7% share drop, with no lawsuit filed yet, Aktien reported. Bragar Eagel & Squire said the same month it was investigating potential securities-law violations on behalf of stockholders following the Q2 fiscal 2027 results, GlobeNewswire reported.

What Comes Next for NVE

Hagens Berman asked investors with substantial losses to submit their trading information and encouraged whistleblowers with non-public information about NVE to come forward under the SEC Whistleblower program.

Companies in this story

Sources

Machine-readable: Markdown · JSON